Calumet (CLMT) EPS (Weighted Average and Diluted) (2023 - 2025)
Calumet (CLMT) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.43 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) rose 14.0% to -$0.43 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.38, a 85.77% increase, with the full-year FY2025 number at -$0.39, up 85.39% from a year prior.
- EPS (Weighted Average and Diluted) was -$0.43 for Q4 2025 at Calumet, down from $3.62 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $3.62 in Q3 2025 to a low of -$1.87 in Q1 2025.
- A 3-year average of -$0.24 and a median of -$0.5 in 2024 define the central range for EPS (Weighted Average and Diluted).
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 406.78% in 2025; the steepest drop was 266.67% in 2025.
- Calumet's EPS (Weighted Average and Diluted) stood at -$0.61 in 2023, then increased by 18.03% to -$0.5 in 2024, then rose by 14.0% to -$0.43 in 2025.
- Per Business Quant, the three most recent readings for CLMT's EPS (Weighted Average and Diluted) are -$0.43 (Q4 2025), $3.62 (Q3 2025), and -$1.7 (Q2 2025).